Strengthening Tuberculosis & HIV/AIDS Response in the Eastern Region of Uganda - (STAR E)
Strengthening Tuberculosis (TB) and HIV/AIDS Responses in East Uganda (STAR-E) main focus is strengthening Tuberculosis and HIV/AIDS prevention, care and treatment in twelve districts of the Eastern region of Uganda (Budaka, Bududa, Bukwa, Busia, Butaleja, Kapchorwa, Mbale, Pallisa, Sironko, Bulambuli,Kween and Kibuku). STAR-E priority result areas include: 1) increased uptake of comprehensive HIV/AIDS and TB services; 2) decentralized service delivery systems strengthened for improved uptake of quality HIV/AIDS and TB services, and institutionalize national Lot Quality Assurance Sample surveys; 3) quality HIV/AIDS and TB services delivered in all supported health facilities and community organizations; 4) networks, linkages and referral systems established or strengthened with and between health facilities and communities to improve access to and uptake of comprehensive HIV/AIDS and TB services; and 5) increased demand for comprehensive HIV/AIDS and TB prevention, care and treatment services.
- ID Projet
US-GOV-1-AID-617-A-00-09-00006
- Statut de l'activité
- 2 - Implementation
- Type d'aide
- C01 - Interventions de type projet
- % to Ouganda
- 100.00
Organisations
- Accountable
- U.S. Agency for International Development
- Extending
- U.S. Agency for International Development
- Funding
- U.S. Agency for International Development
- Implementing
- Management Sciences for Health
Versements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2017 |
Q4 |
-106,701.22 |
-106,701.22 |
2017 |
Q2 |
4,597.39 |
4,597.39 |
2017 |
Q1 |
759,404.86 |
759,404.86 |
2016 |
Q4 |
878,743.46 |
878,743.46 |
2016 |
Q3 |
1,896,383.33 |
1,896,383.33 |
2016 |
Q2 |
906,643.24 |
906,643.24 |
2016 |
Q1 |
1,281,836.76 |
1,281,836.76 |
2015 |
Q4 |
1,814,663.25 |
1,814,663.25 |
2015 |
Q3 |
517,241.67 |
517,241.67 |
2015 |
Q2 |
1,170,196.90 |
1,170,196.90 |
2015 |
Q1 |
1,053,772.23 |
1,053,772.23 |
2014 |
Q4 |
1,347,500.00 |
1,347,500.00 |
2014 |
Q3 |
948,000.00 |
948,000.00 |
2014 |
Q2 |
718,000.00 |
718,000.00 |
2014 |
Q1 |
3,086,000.00 |
3,086,000.00 |
2013 |
Q4 |
2,083,000.00 |
2,083,000.00 |
2013 |
Q3 |
1,606,871.00 |
1,606,871.00 |
2013 |
Q2 |
2,100,000.00 |
2,100,000.00 |
2013 |
Q1 |
2,014,000.00 |
2,014,000.00 |
2012 |
Q4 |
1,606,000.00 |
1,606,000.00 |
2012 |
Q3 |
1,559,000.00 |
1,559,000.00 |
2012 |
Q2 |
1,241,000.00 |
1,241,000.00 |
2012 |
Q1 |
1,160,000.00 |
1,160,000.00 |
2011 |
Q4 |
1,839,000.00 |
1,839,000.00 |
2011 |
Q3 |
1,855,000.00 |
1,855,000.00 |
2011 |
Q2 |
2,007,000.00 |
2,007,000.00 |
2011 |
Q1 |
2,305,000.00 |
2,305,000.00 |
2010 |
Q4 |
1,692,000.00 |
1,692,000.00 |
2010 |
Q3 |
1,292,000.00 |
1,292,000.00 |
2010 |
Q2 |
1,235,000.00 |
1,235,000.00 |
2010 |
Q1 |
1,533,000.00 |
1,533,000.00 |
2009 |
Q4 |
1,735,000.00 |
1,735,000.00 |
2009 |
Q3 |
2,081,000.00 |
2,081,000.00 |
2009 |
Q2 |
1,168,000.00 |
1,168,000.00 |
2009 |
Q1 |
927,000.00 |
927,000.00 |
2008 |
Q4 |
360,000.00 |
360,000.00 |
Engagements par exercice fiscal, trimestre
Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
2016 |
Q2 |
3,500,000.00 |
3,500,000.00 |
2016 |
Q1 |
886,405.00 |
886,405.00 |
2015 |
Q3 |
3,598,842.00 |
3,598,842.00 |
2014 |
Q4 |
3,659,082.00 |
3,659,082.00 |
2014 |
Q1 |
1,580,242.00 |
1,580,242.00 |
2013 |
Q3 |
6,032,349.00 |
6,032,349.00 |
2013 |
Q1 |
3,433,588.00 |
3,433,588.00 |
2012 |
Q3 |
2,769,691.00 |
2,769,691.00 |
2012 |
Q1 |
3,481,878.00 |
3,481,878.00 |
2011 |
Q4 |
1,429,863.00 |
1,429,863.00 |
2011 |
Q3 |
3,000,000.00 |
3,000,000.00 |
2011 |
Q1 |
1,998,741.00 |
1,998,741.00 |
2010 |
Q3 |
3,600,000.00 |
3,600,000.00 |
2009 |
Q4 |
5,457,110.00 |
5,457,110.00 |
2009 |
Q2 |
2,000,000.00 |
2,000,000.00 |
2008 |
Q3 |
3,800,000.00 |
3,800,000.00 |
Projections de CDMT par exercice fiscal
Exercice fiscal |
Montant (USD) |
Ouganda Montant (USD) |
Code CRS |
% |
Lutte contre la tuberculose
(12263)
|
7.07
|
Lutte contre les MST et VIH/sida
(13040)
|
92.93
|